Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001326405 | SCV001517435 | likely benign | Bethlem myopathy 1A | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002546177 | SCV003569013 | uncertain significance | Inborn genetic diseases | 2021-08-12 | criteria provided, single submitter | clinical testing | The c.4226C>T (p.T1409M) alteration is located in exon 9 (coding exon 8) of the COL6A3 gene. This alteration results from a C to T substitution at nucleotide position 4226, causing the threonine (T) at amino acid position 1409 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |